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Purpose: Deep brain stimulation using a neurocybernetic device and intracranially implanted electrodes is currently being 
investigated as a treatment for refractory epilepsy. Several brain structures such as the cerebellum and the thalamus have 
been targeted. At Ghent University Hospital a pilot trial in patients using hippocampal DBS has shown a significant 
reduction in seizure frequency in patients with temporal lobe epilepsy. The current stimulation parameters that are being 
used are not evidence based. Further improvement of clinical efficacy may result from research towards the identification 
of optimal stimulation parameters in specific seizure types. This study investigated the efficacy of hippocampal DBS using 
two different stimulation frequencies in a validated animal model for temporal lobe epilepsy. 
Methods: Twenty rats were transformed into epileptic rats using the alternate day rapid kindling model that makes use of 
electrical stimuli in the amygdala. When fully kindled, these rats have a seizure each time an electrical stimulus is 
administered in the hippocampus. For therapeutic hippocampal stimulation rats were divided into a 130 Hz (HFS) group 
and a 5 Hz (LFS) stimulation group.  Rats received 10 days of therapeutic hippocampal DBS. During and after termination 
of therapeutic DBS, seizures were evoked in all rats using the amygdalar electrical stimulation. Typical seizure 
characteristics such as after discharge (AD) threshold, latency and duration were compared between both treatment 
groups.   
Results: During HFS, AD threshold and AD latency showed a significantly larger increase (P<0.05 and p<0.005 
respectively) compared to the rats that received LFS (p=0.48 and p<0.05 respectively).In the HFS group the AD duration 
was shorter (p<0.05) compared to baseline. This was not observed in the LFS group. After termination of DBS, effects 
faded out slowly. 
  
Discussion and Conclusion: Both HFS and LFS of the hippocampus in epileptic rats resulted in reduced excitability that is 
typical for epileptic seizures. When HFS and LFS were compared, HFS was more efficacious the n LFS as reflected in a 
higher AD threshold and AD latency and a shorter AD duration during treatment. This study is the first to show clear 
evidence in favour of HFS of the hippocampus to treat seizures. 
 
